Hepatitis C treatment outcomes among people who inject drugs accessing harm reduction settings in Kenya
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Journal of viral hepatitis - 29(2022), 8 vom: 02. Aug., Seite 691-694 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Akiyama, Matthew J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Africa |
|---|
| Anmerkungen: |
Date Completed 12.07.2022 Date Revised 02.08.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/jvh.13662 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338052208 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338052208 | ||
| 003 | DE-627 | ||
| 005 | 20231225235812.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jvh.13662 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1126.xml |
| 035 | |a (DE-627)NLM338052208 | ||
| 035 | |a (NLM)35274394 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Akiyama, Matthew J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hepatitis C treatment outcomes among people who inject drugs accessing harm reduction settings in Kenya |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.07.2022 | ||
| 500 | |a Date Revised 02.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Africa | |
| 650 | 4 | |a DAA | |
| 650 | 4 | |a HCV | |
| 650 | 4 | |a LMIC | |
| 650 | 4 | |a PWID | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 700 | 1 | |a Riback, Lindsey R |e verfasserin |4 aut | |
| 700 | 1 | |a Nyakowa, Mercy |e verfasserin |4 aut | |
| 700 | 1 | |a Musyoki, Helgar |e verfasserin |4 aut | |
| 700 | 1 | |a Lizcano, John A |e verfasserin |4 aut | |
| 700 | 1 | |a Muller, Abbe |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Chenshu |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, Josephine G |e verfasserin |4 aut | |
| 700 | 1 | |a Stone, Jack |e verfasserin |4 aut | |
| 700 | 1 | |a Vickerman, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Cherutich, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Kurth, Ann E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of viral hepatitis |d 1997 |g 29(2022), 8 vom: 02. Aug., Seite 691-694 |w (DE-627)NLM074659642 |x 1365-2893 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2022 |g number:8 |g day:02 |g month:08 |g pages:691-694 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jvh.13662 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2022 |e 8 |b 02 |c 08 |h 691-694 | ||